Revolutionizing Vascular Grafting. Developer of an innovative
vascular stapling technology for open, laparoscopic and
endovascular aortic grafting procedures.
Employees: 9
Main Markets:
Hospitals.
Overview
ES VASCULAR LTD. developed first ever surgical stapling devices
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
for endovascular surgery. These innovative devices aim to
transform vascular surgery by shortening procedural times, and by
simplifying and potentially increasing the safety of the most
common vascular interventions. The company's staplers are aimed
at replacing current lengthy, complicated and/or hazardous
vascular grafting with a rapid, simple and safe attachment method
for synthetic vascular grafts.
Use of the company's revolutionary staplers is intended to
significantly reduce both vascular clamping and total operating
time, and consequently mortality, morbidity, hospitalization and
ICU time for such patients. It is hoped that ES VASCULAR's
technology will revolutionize surgical practice by transforming
many open vascular aneurism surgery cases into laparoscopic
procedures, as well as significantly expanding the number of
endo-vascular procedures.
ES VASCULAR anticipates commencing pivotal clinical trials of its
devices in Europe and the US eminently.
The company is currently developing three product lines for open
AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first
products are anticipated to enter the market in 2008.
